News

Video

Initial Treatment Options for Metastatic TNBC

Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
image of Kelsey Martin
Photo of Dr. Tran Ho
Dr. William Audeh explains how treatment decisions for breast cancer can be informed by a patient’s ultra-low, low or high genomic risk status.